Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Atorvastatin side effects heart palpitations?What's the advised delay for milk post lipitor?How might diet alleviate lipitor's liver impact?Generic brand for latisse?Dabrafenib patent expiration?
See the DrugPatentWatch profile for lurbinectedin
Lurbinectedin (Zepzelca), used for metastatic small cell lung cancer, has high costs—often $15,000+ per dose. Jazz Pharmaceuticals offers the Zepzelca Copay Assistance Program, which covers copays, coinsurance, or deductibles up to $25,000 per year for commercially insured patients. Eligibility requires U.S. residency, valid prescription, and no government insurance like Medicare/Medicaid. Apply via ZepzelcaAccess.com or call 1-833-4ZEPZEL (1-833-493-7935).[1][2]
The Zepzelca Patient Assistance Program provides free medication to uninsured or underinsured patients meeting income guidelines (typically ≤400-500% of federal poverty level). No copay required; approval can take days to weeks. Contact Jazz Cares at 1-800-255-5163 or apply online.[1][3]
Programs prioritize financial need via income proof (tax returns, pay stubs). Commercial patients use copay cards instantly at pharmacies; others get shipped drugs. Reapply annually. Independent foundations like Patient Access Network (PAN) or CancerCare may bridge gaps if ineligible—PAN covers up to $10,800 yearly for lung cancer drugs.[4][5]
Other Questions About Lurbinectedin :